Cell and gene therapy companies develop advanced treatments that modify, replace or engineer cells and genetic material to treat disease. The field is one of the fastest-growing areas of biotechnology and precision medicine.
This category includes companies working on:
Browse 144 UK cell and gene therapy companies below.
Immune cell separation and expansion platform for cell therapies
CoED Biosciences is a biotech developing the Column of Expansion and Differentiation (CoED) platform, a consumable device integrating immune cell separation, functionalisation,…
Non-viral gene therapy platform enabling durable nuclear DNA delivery
Gramics Bio develops a gene therapy platform solving a key limitation of lipid nanoparticle delivery: enabling therapeutic DNA to reach the cell nucleus for durable expression…
RNA-based gene control systems for safer cell and gene therapies
Concinnity Genetics is a biotechnology company developing RNA-based control systems that enable precise regulation of gene therapies after administration. Its technology allows…
Immuno-oncology therapies targeting the nfP2X7 cancer receptor
Biosceptre is a UK-headquartered clinical-stage biotechnology company developing cancer therapeutics based on its proprietary nfP2X7 platform. The nfP2X7 receptor is a…
Private umbilical cord blood and tissue stem cell banking service
Future Health Biobank is the UK's largest private stem cell bank, providing collection, processing, and long-term cryogenic storage of umbilical cord blood and cord tissue for…
Gene therapies targeting cancer stem cells in solid tumours
Cellinta is a pre-clinical biotechnology company developing highly selective gene therapies for solid tumour cancers. Its platform identifies transcriptional regulatory circuits…
End-to-end viral vector design, production and gene delivery
VectorBuilder is a global provider of gene delivery solutions offering an integrated suite of research products, custom services, and clinical-grade manufacturing. The company's…
Individualised neoantigen-based cell therapies for ovarian and solid cancers
Singula Bio is a seed-stage biotechnology company developing individualised, neoantigen-based cell therapies for patients with solid tumours, with an initial focus on ovarian…
Cell and gene therapy CDMO with integrated consultancy services
eXmoor Pharma is a Bristol-based contract development and manufacturing organisation specialising in cell and gene therapies. Operating from a 65,000 sq ft MHRA-licensed GMP…
Oncolytic vaccinia virus platform targeting refractory solid tumours
VacV Biotherapeutics is a cancer immunotherapy company developing engineered oncolytic Vaccinia virus-based therapeutics for the treatment of solid tumours. Spun out of Barts…
Biomimetic cell culture platform for reproducible cell therapy development
Stembond Technologies is a Cambridge University spin-out developing a synthetic, mechanically tuned biomimetic substrate that replicates the physical properties of human tissue…
Global cell and gene therapy CDMO
Minaris Advanced Therapies is a company providing contract development, manufacturing and testing services across the cell and gene therapy lifecycle. Its UK operations originate…